Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuru Deng has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lipid and Transcriptional Regulation in a Parkinson's Disease Mouse Model by Intranasal Vesicular and Hexosomal Plasmalogen‐Based Nanomedicines

    by Yu Wu, Jieli Wang, Yuru Deng, Borislav Angelov, Takehiko Fujino, Shamim Hossain, Angelina Angelova

    Plasmalogens (vinyl‐ether phospholipids) are an emergent class of lipid drugs against various diseases involving neuro‐inflammation, oxidative stress, mitochondrial dysfunction, and altered lipid metabolism. They can activate neurotrophic and neuroprotective signaling pathways but low bioavailabilities limit their efficiency in curing neurodegeneration. Here, liquid crystalline lipid nanoparticles (LNPs) are created for the protection and non‐invasive intranasal delivery of purified scallop‐derived plasmalogens. The in vivo results with a transgenic mouse Parkinson's disease (PD) model (characterized by motor impairments and α‐synuclein deposition) demonstrate the crucial importance of LNP composition, which determines the self‐assembled nanostructure type. Vesicle and hexosome nanostructures (characterized by small‐angle X‐ray scattering) display different efficacy of the nanomedicine‐mediated recovery of motor function, lipid balance, and transcriptional regulation (e.g., reduced neuro‐inflammation and PD pathogenic gene expression). Intranasal vesicular and hexosomal plasmalogen‐based LNP treatment leads to improvement of the behavioral PD symptoms and downregulation of the Il6, Il33, and Tnfa genes. Moreover, RNA‐sequencing and lipidomic analyses establish a dramatic effect of hexosomal nanomedicines on PD amelioration, lipid metabolism, and the type and number of responsive transcripts that may be implicated in neuroregeneration.


  • Open Access

    Optical Properties and Interference Effects of the Lens Mitochondrion

    by Felix Margadant, Zakaria Almsherqi, Xiaochun Xu, Yuru Deng

    The lens mitochondrion of the tree shrew, located along the optical pathway between the lens and photoreceptors, has been investigated. The results suggest that the lens mitochondrion acts as a quasi-bandgap or imperfect photonic crystal. Interference effects cause a shift in the focus and introduce wavelength-dependent behavior similar to dispersion. Optical channels within the mitochondrion form a mild waveguide, preferentially propagating light within certain compartments. The lens mitochondrion also functions as an imperfect UV-shielding interference filter. Overall, this study provides insights into the dual role of the lens mitochondrion and the complex behavior of light within biological systems.


  • Open Access

    Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery

    by Yu Wu, Miora Rakotoarisoa, Borislav Angelov, Yuru Deng, Angelina Angelova

    Enabling challenging applications of nanomedicine and precision medicine in the treatment of neurodegenerative disorders requires deeper investigations of nanocarrier-mediated biomolecular delivery for neuronal targeting and recovery. The successful use of macromolecular biotherapeutics (recombinant growth factors, antibodies, enzymes, synthetic peptides, cell-penetrating peptide–drug conjugates, and RNAi sequences) in clinical developments for neuronal regeneration should benefit from the recent strategies for enhancement of their bioavailability. We highlight the advances in the development of nanoscale materials for drug delivery in neurodegenerative disorders. The emphasis is placed on nanoformulations for the delivery of brain-derived neurotrophic factor (BDNF) using different types of lipidic nanocarriers (liposomes, liquid crystalline or solid lipid nanoparticles) and polymer-based scaffolds, nanofibers and hydrogels. Self-assembled soft-matter nanoscale materials show favorable neuroprotective characteristics, safety, and efficacy profiles in drug delivery to the central and peripheral nervous systems. The advances summarized here indicate that neuroprotective biomolecule-loaded nanoparticles and injectable hydrogels can improve neuronal survival and reduce tissue injury. Certain recently reported neuronal dysfunctions in long-COVID-19 survivors represent early manifestations of neurodegenerative pathologies. Therefore, BDNF delivery systems may also help in prospective studies on recovery from long-term COVID-19 neurological complications and be considered as promising systems for personalized treatment of neuronal dysfunctions and prevention or retarding of neurodegenerative disorders.


  • Open Access

    Plasmalogenic Lipid Analogs as Platelet-Activating Factor Antagonists: A Potential Novel Class of Anti-inflammatory Compounds

    by Pu Rong, Jie-Li Wang, Angelina Angelova, Zakaria A. Almsherqi, Yuru Deng

    Plasmalogens and Platelet-Activating Factor (PAF) are both bioactive ether phospholipids. Whereas plasmalogens are recognized for their important antioxidant function and modulatory role in cell membrane structure and dynamics, PAF is a potent pro-inflammatory lipid mediator known to have messenger functions in cell signaling and inflammatory response. The relationship between these two types of lipids has been rarely studied in terms of their metabolic interconversion and reciprocal modulation of the pro-inflammation/anti-inflammation balance. The vinyl-ether bonded plasmalogen lipid can be the lipid sources for the precursor of the biosynthesis of ether-bonded PAF. In this opinion paper, we suggest a potential role of plasmalogenic analogs of PAF as modulators and PAF antagonists (anti-PAF). We discuss that the metabolic interconversion of these two lipid kinds may be explored towards the development of efficient preventive and relief strategies against PAF-mediated pro-inflammation. We propose that plasmalogen analogs, acting as anti-PAF, may be considered as a new class of bioactive anti-inflammatory drugs. Despite of the scarcity of available experimental data, the competition between PAF and its natural plasmalogenic analogs for binding to the PAF receptor (PAF-R) can be proposed as a mechanistic model and potential therapeutic perspective against multiple inflammatory diseases (e.g., cardiovascular and neurodegenerative disorders, diabetes, cancers, and various manifestations in coronavirus infections such as COVID-19).


  • Open Access

    Plasmalogen‐rich foods promote the formation of cubic membranes in amoeba Chaos under stress conditions

    by Ketpin Chong, Zakaria A. Almsherqi, Ruijiang Zhuo, Yuru Deng

    Previous studies have indicated that the ability to form cubic membrane (CM), a three‐dimensional periodic structure with cubic symmetry, in amoeba (Chaos carolinense) under stress conditions depends on the type of food organism supplied before cell starvation. The significant increase in docosapentaenoic acid (DPA; C22:5n‐6) during the starvation period has been reported to induce CM formation and support Chaos cell survival. In this article, we further investigated the lipid profiles of food organisms of the Chaos cells to reveal the key lipid components that might promote CM formation. Our results show that the lipids extracted from cells of the native food organism Paramecium multimicronucleatum are enriched in plasmalogens. More specifically, plasmalogen phosphatidylcholine and plasmalogen phosphatidylethanolamine might be the key lipids that trigger CM formation in Chaos cells under starvation stress conditions. Unexpectedly, CM formation in these cells is not supported when the native food organism was replaced with plasmalogen‐deficit Tetrahymena pyriformis cells. Based on a previous lipidomics study on amoeba Chaos and this study on the lipid composition of its food organisms, three key lipids (plasmalogen phosphatidylcholine, plasmalogen phosphatidylethanolamine and diacyl‐phosphatidylinositol) were identified and used for liposomal construction. Our in vitro study revealed the potential role of these lipids in a nonlamellar phase transition. The negative staining transmission electron microscopy data of our liposomal constructs support the notion that plasmalogens may curve the membrane, which, in turn, may facilitate membrane fusion and vesicular formation, which is crucial for membrane dynamics and trafficking.


  • Open Access

    Coronavirus-Induced Host Cubic Membranes and Lipid-Related Antiviral Therapies: A Focus on Bioactive Plasmalogens

    by Yuru Deng, Angelina Angelova

    Coronaviruses have lipid envelopes required for their activity. The fact that coronavirus infection provokes the formation of cubic membranes (CM) (denoted also as convoluted membranes) in host cells has not been rationalized in the development of antiviral therapies yet. In this context, the role of bioactive plasmalogens (vinyl ether glycerophospholipids) is not completely understood. These lipid species display a propensity for non-lamellar phase formation, facilitating membrane fusion, and modulate the activity of membrane-bound proteins such as enzymes and receptors. At the organism level, plasmalogen deficiency is associated with cardiometabolic disorders including obesity and type 2 diabetes in humans. A straight link is perceived with the susceptibility of such patients to SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2) infection, the severity of illness, and the related difficulty in treatment. Based on correlations between the coronavirus-induced modifications of lipid metabolism in host cells, plasmalogen deficiency in the lung surfactant of COVID-19 patients, and the alterations of lipid membrane structural organization and composition including the induction of CM, we emphasize the key role of plasmalogens in the coronavirus (SARS-CoV-2, SARS-CoV, or MERS-CoV) entry and replication in host cells. Considering that plasmalogen-enriched lung surfactant formulations may improve the respiratory process in severe infected individuals, plasmalogens can be suggested as an anti-viral prophylactic, a lipid biomarker in SARS-CoV and SARS-CoV-2 infections, and a potential anti-viral therapeutic component of lung surfactant development for COVID-19 patients.


  • Open Access

    The Potential Role of Bioactive Plasmalogens in Lung Surfactant

    by Ruijiang Zhuo, Pu Rong, Jieli Wang, Rokshana Parvin, Yuru Deng

    Neonatal respiratory distress syndrome (NRDS) is a type of newborn disorder caused by the deficiency or late appearance of lung surfactant, a mixture of lipids and proteins. Studies have shown that lung surfactant replacement therapy could effectively reduce the morbidity and mortality of NRDS, and the therapeutic effect of animal-derived surfactant preparation, although with its limitations, performs much better than that of protein-free synthetic ones. Plasmalogens are a type of ether phospholipids present in multiple human tissues, including lung and lung surfactant. Plasmalogens are known to promote and stabilize non-lamellar hexagonal phase structure in addition to their significant antioxidant property. Nevertheless, they are nearly ignored and underappreciated in the lung surfactant-related research. This report will focus on plasmalogens, a minor yet potentially vital component of lung surfactant, and also discuss their biophysical properties and functions as anti-oxidation, structural modification, and surface tension reduction at the alveolar surface. At the end, we boldly propose a novel synthetic protein-free lung surfactant preparation with plasmalogen modification as an alternative strategy for surfactant replacement therapy.


  • Open Access

    Bicontinuous cubic phases in biological and artificial self-assembled systems

    by Congcong Cui, Yuru Deng, Lu Han

    Nature has created innumerable life forms with miraculous hierarchical structures and morphologies that are optimized for different life events through evolution over billions of years. Bicontinuous cubic structures, which are often described by triply periodic minimal surfaces (TPMSs) and their constant mean curvature (CMC)/parallel surface companions, are of special interest to various research fields because of their complex form with unique physical functionalities. This has prompted the scientific community to fully understand the formation, structure, and properties of these materials. In this review, we summarize and discuss the formation mechanism and relationships of the relevant biological structures and the artificial self-assembly systems. These structures can be formed through biological processes with amazing regulation across a great length scales; nevertheless, artificial construction normally produces the structure corresponding to the molecular size and shape. Notably, the block copolymeric system is considered to be an applicable and attractive model system for the study of biological systems due to their versatile design and rich phase behavior. Some of the phenomena found in these two systems are compared and discussed, and this information may provide new ideas for a comprehensive understanding of the relationship between molecular shape and resulting interface curvature and the self-assembly process in living organisms. We argue that the co-polymeric system may serve as a model to understand these biological systems and could encourage additional studies of artificial self-assembly and the creation of new functional materials.